OverviewSuggest Edit

Moderna is pioneering messenger RNA therapeutics™, an entirely new in vivo drug modality that produces human proteins or antibodies inside patient cells, which are in turn active intracellularly or secreted. This breakthrough platform addresses currently undruggable targets, and offers an alternative to existing drug modalities for a wide range of disease conditions.

TypePublic
HQCambridge, US
Websitemodernatx.com
Employee Ratings3.7

Latest Updates

Employees (est.) (Dec 2019)830(+10%)
Job Openings175
Revenue (FY, 2019)$60.2 M(-55%)
Share Price (Sept 2020)$63.7 (+8%)
Cybersecurity ratingAMore

Key People/Management at Moderna

Stephane Bancel

Stephane Bancel

Chief Executive Officer, Director
Paul Sagan

Paul Sagan

Director
Stephen Hoge

Stephen Hoge

President
Henri A. Termeer

Henri A. Termeer

Director
Tracey Franklin

Tracey Franklin

Chief Human Resources Officer
Stephen Berenson

Stephen Berenson

Director
Show more

Moderna Office Locations

Moderna has offices in Cambridge, Norwood, Chicago, Huntington and in 1 other location
Cambridge, US (HQ)
200 Technology Square
Cambridge, US
NE47, 500 Technology Square
Norwood, US
100 Upland Rd
Huddinge, SE
Hälsovägen 7-9
Show all (6)

Moderna Financials and Metrics

Moderna Revenue

Moderna's revenue was reported to be $60.21 m in FY, 2019
USD

Revenue (Q2, 2020)

28.4m

Market capitalization (14-Sept-2020)

25.1b

Closing stock price (14-Sept-2020)

63.7

Cash (30-Jun-2020)

1.8b

EV

23.5b
Moderna's current market capitalization is $25.1 b.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

108.4m205.8m135.1m60.2m

Revenue growth, %

90%

General and administrative expense

57.5m64.7m94.3m109.6m

R&D expense

274.7m410.5m454.1m496.3m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

16.0m13.1m17.0m8.4m28.4m

General and administrative expense

27.3m28.5m28.2m24.1m

R&D expense

130.6m128.5m119.7m115.1m

Operating expense total

157.9m157.0m147.9m139.3m
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

50.1m134.9m658.4m235.9m

Accounts Receivable

13.4m11.9m11.7m5.0m

Prepaid Expenses

15.5m12.8m28.4m19.4m

Current Assets

1.1b783.2m1.6b1.1b
Quarterly
USDQ3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

167.1m502.9m151.6m173.7m391.7m1.8b

Accounts Receivable

9.8m5.6m3.5m2.8m5.6m33.4m

Prepaid Expenses

33.4m25.3m23.9m45.3m

Current Assets

1.1b1.1b1.1b1.1b1.2b2.8b
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(216.2m)(255.9m)(514.0m)

Depreciation and Amortization

17.6m21.6m24.9m31.0m

Accounts Payable

6.0m(12.8m)15.0m(24.0m)

Cash From Operating Activities

66.7m(331.5m)(330.9m)(459.0m)
Quarterly
USDQ3, 2017Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(243.3m)(218.0m)(132.7m)(267.7m)(390.9m)(124.2m)(240.9m)

Depreciation and Amortization

58.4m43.6m7.3m14.8m22.1m15.0m

Accounts Payable

718.0k(9.9m)1.7m(1.5m)(19.2m)2.3m11.5m

Cash From Operating Activities

(239.8m)(228.6m)(143.9m)(256.1m)(363.2m)(106.2m)(130.1m)
USDFY, 2016

Revenue/Employee

302.9k

Financial Leverage

-4.2 x
Show all financial metrics

Moderna Operating Metrics

Moderna's Clinical Programs was reported to be 10 in Q3, 2018.
Y, 2015May, 2017Q3, 2018

Clinical Programs

10

Drugs in Development

92

Patent Applications

250

Patents Issued

100
Show all operating metrics

Moderna Acquisitions / Subsidiaries

Company NameDateDeal Size
Brizo
Moderna AB
Moderna Securities
ModernaTX

Moderna Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Moderna Revenue Breakdown

Embed Graph

Moderna revenue breakdown by business segment: 14.0% from Grant revenue, 14.6% from Collaboration revenue from affiliate and 71.4% from Collaboration revenue

Moderna Online and Social Media Presence

Embed Graph

Moderna News and Updates

Moderna would never release coronavirus vaccine data different from 'reality,' chairman says

The company put out the extent of data it had available, Moderna Chairman Noubar Afeyan tells CNBC.

Morgan Stanley now sees Moderna shares spiking 26% from current levels, cites 65% chance of success for virus vaccine (MRNA)

Morgan Stanley raised its Moderna price target to $90 from $37, citing "initial promising Covid-19 vaccine data," according to a Wednesday note.  That's a 26% jump from where shares of Moderna currently trade.  The bank risk-adjusted its estimates following the early results of the vaccine and no…

Lonza CEO says on pace to make Moderna trial vaccine in June/July - CNBC

Contract drug manufacturer Lonza still expects to supply drugmaker Moderna with active ingredients for its experimental COVID-19 vaccine by June or July to support laboratory trials, the Swiss company's interim CEO, Albert Baehny, told CNBC on Wednesday.

Dow futures struggle for direction Tuesday evening after Moderna vaccine report sparks Dow's 390-point skid

U.S. stock-index futures ticked higher in thinly traded bumpy action Tuesday evening after the Dow snapped a three-session win streak in the last hour of the regular session, following a report that cast doubt on a coronavirus remedy. Futures for the Dow Jones Industrial Average rose 0.2% at 24,194…

Scientists Raise Questions About Moderna Vaccine In Market-Shaking Report

They have to publish a scientific paper, opting for issuing press releases instead.

Stocks making the biggest moves after hours: Urban Outfitters, Moderna, Johnson & Johnson and more

Check out the companies making headlines after the bell.
Show more

Moderna Blogs

Moderna Reports 2019 Fourth Quarter and Full Year Financial Results and Highlights Advancements in Core Modalities

Two of three dose cohorts in Phase 2 CMV vaccine (mRNA-1647) dose-confirmation study completed enrollment; third and final cohort rapidly enrolling Up to $2 billion to invest, including cash and investments, financing proceeds and potentially available grants; reiterates guidance that net cash used

Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study

mRNA-1273 delivered from Company’s cGMP facility in 42 days from sequence selection CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 24, 2020-- Moderna, Inc. , (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of

Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020

Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020 Content Import Wed, 02/12/2020 - 16:30 Moderna to Report Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26th, 2020 February 12, 2020 at 4:30 PM…

Moderna Announces Pricing of Public Offering of Shares of Common Stock

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Feb. 11, 2020-- Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced the pricing of an underwritten

Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates

Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates Content Import Mon, 02/10/2020 - 17:11 Moderna Announces Progress in Prophy…

Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia

Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia Content Import Mon, 02/10/2020 - 17:10 Moderna Announces First Patient Enrolled in Phase 1/2 Study of mRNA-3704 for Methylmalonic Acidemia February 10, 2020 at 5:10 PM EST …
Show more

Moderna Frequently Asked Questions

  • Who are Moderna key executives?

    Moderna's key executives are Stephane Bancel, Paul Sagan and Stephen Hoge.

  • How many employees does Moderna have?

    Moderna has 830 employees.

  • What is Moderna revenue?

    Latest Moderna annual revenue is $60.2 m.

  • What is Moderna revenue per employee?

    Latest Moderna revenue per employee is $72.5 k.

  • Who are Moderna competitors?

    Competitors of Moderna include Celyad, CureVac and Regulus Therapeutics.

  • Where is Moderna headquarters?

    Moderna headquarters is located at 200 Technology Square, Cambridge.

  • Where are Moderna offices?

    Moderna has offices in Cambridge, Norwood, Chicago, Huntington and in 1 other location.

  • How many offices does Moderna have?

    Moderna has 6 offices.